Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced partner
93pts. Had a couple of requests for this during the week, so here it is! 🌱 Vineyard: Lower Tintara, Kays Rd - originally planted by Thomas Hardy in the 1880s. 🪨 Soils: Maslin Sands, laid down ... Read Full Article →
New Delhi: Old Delhi's 13 protected monuments and their parts including Red Fort's Diwan-i-Aam, Mumtaz Mahal, Diwan-i-Khas, Delhi Gate, Ajmeri Gate an. Read Full Article →
New Delhi: Over a decade after a govt bank was allegedly duped of over Rs 4.1 crore in southwest Delhi's Najafgarh, the Central Bureau of Investigatio. Read Full Article →
iShares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than smaller speculative names. That structure can offer more earnings visibility, but it also means giving up some upside when risk appetite shifts toward early-stage biotech companies. Read Full Article →
